WHO defines Pharmacovigilance as “the pharmacological science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problem”. The challenge of maximizing drug safety and maintaining public confidence has become increasingly complex. Pharmaceutical and biotechnology companies must not only monitor, but also proactively assess and manage drug risk throughout a product’s lifecycle from development to post market. The Pharmacovigilance team at Leeford Healthcare Limited aims to assure the safety of medicines by ensuring reliable and timely exchange of information on safety issues, promoting pharmacovigilance activities throughout the Organization and encouraging its participation in the National & International Drug Monitoring programme through PvPI.
Pharmacovigilance Programme of India (PvPI) was launched by the Ministry of Health & Family Welfare (MoHFW), Government of India in the year 2010 at AIIMS New Delhi as National Coordinating Centre (NCC) & today finally it stands as National Coordination Centre-Pharmacovigilance Programme of India at Indian Pharmacopoeia Commission, Ghaziabad under MoHFW and has emerged to became a WHO Collaborating Centre for Pharmacovigilance in Public Health Programmes & Regulatory services from July, 2017. Thus the national PvPI has emerged now to become an International programme of repute.
To report side effects and related problems about the drugs can connect with us at firstname.lastname@example.org via mail or can download the attached form and send it back to ahead mentioned ID & also at email@example.com or firstname.lastname@example.org. You can also simultaneously inform the central body if you want at below mails i.e. email@example.com & firstname.lastname@example.org.